Abstract
Nucleotide-dependent unblocking of chain-terminated DNA by human immunodeficiency virus type 1 reverse transcriptase (RT) is enhanced by the presence of mutations associated with 3'-azido-3'-deoxythymidine (AZT) resistance. The increase in unblocking activity was greater for mutant combinations associated with higher levels of in vivo AZT resistance. The difference between mutant and wild-type activity was further enhanced by introduction of a methyl group into the nucleotide substrate and was decreased for a nonaromatic substrate, suggesting that pi-pi interactions between RT and an aromatic structure may be facilitated by these mutations.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Antiviral Agents / pharmacology*
-
DNA Primers
-
Dinucleoside Phosphates / chemistry
-
Dinucleoside Phosphates / metabolism
-
Drug Resistance, Viral
-
HIV Reverse Transcriptase / drug effects
-
HIV Reverse Transcriptase / genetics*
-
HIV-1 / drug effects
-
HIV-1 / enzymology
-
Models, Molecular
-
Mutation*
-
Nucleotides / chemistry*
-
Nucleotides / metabolism
-
Reverse Transcriptase Inhibitors / pharmacology*
-
Substrate Specificity
-
Templates, Genetic
-
Zidovudine / pharmacology*
Substances
-
Antiviral Agents
-
DNA Primers
-
Dinucleoside Phosphates
-
Nucleotides
-
Reverse Transcriptase Inhibitors
-
Zidovudine
-
HIV Reverse Transcriptase